Global Cardiovascular Chinese Patent Medicine Production, Demand and Key Producers, 2022-2028
This report studies the global Cardiovascular Chinese Patent Medicine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cardiovascular Chinese Patent Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiovascular Chinese Patent Medicine that contribute to its increasing demand across many markets.
The global Cardiovascular Chinese Patent Medicine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Cardiovascular Chinese Patent Medicine total production and demand, 2017-2028, (K Units)
Global Cardiovascular Chinese Patent Medicine total production value, 2017-2028, (USD Million)
Global Cardiovascular Chinese Patent Medicine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Cardiovascular Chinese Patent Medicine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Cardiovascular Chinese Patent Medicine domestic production, consumption, key domestic manufacturers and share
Global Cardiovascular Chinese Patent Medicine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Cardiovascular Chinese Patent Medicine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Cardiovascular Chinese Patent Medicine production by Sales Channels production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Cardiovascular Chinese Patent Medicine market based on the following parameters – headquarters, production locations, products portfolio, Cardiovascular Chinese Patent Medicine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cardiovascular Chinese Patent Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Sales Channels. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Cardiovascular Chinese Patent Medicine Market, By Region:
1. How big is the global Cardiovascular Chinese Patent Medicine market?
2. What is the demand of the global Cardiovascular Chinese Patent Medicine market?
3. What is the year over year growth of the global Cardiovascular Chinese Patent Medicine market?
4. What is the production and production value of the global Cardiovascular Chinese Patent Medicine market?
5. Who are the key producers in the global Cardiovascular Chinese Patent Medicine market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Cardiovascular Chinese Patent Medicine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cardiovascular Chinese Patent Medicine that contribute to its increasing demand across many markets.
The global Cardiovascular Chinese Patent Medicine market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Cardiovascular Chinese Patent Medicine total production and demand, 2017-2028, (K Units)
Global Cardiovascular Chinese Patent Medicine total production value, 2017-2028, (USD Million)
Global Cardiovascular Chinese Patent Medicine production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Cardiovascular Chinese Patent Medicine consumption by region & country, CAGR, 2017-2028 & (K Units)
U.S. VS China: Cardiovascular Chinese Patent Medicine domestic production, consumption, key domestic manufacturers and share
Global Cardiovascular Chinese Patent Medicine production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (K Units)
Global Cardiovascular Chinese Patent Medicine production by Type, production, value, CAGR, 2017-2028, (USD Million) & (K Units)
Global Cardiovascular Chinese Patent Medicine production by Sales Channels production, value, CAGR, 2017-2028, (USD Million) & (K Units)
This reports profiles key players in the global Cardiovascular Chinese Patent Medicine market based on the following parameters – headquarters, production locations, products portfolio, Cardiovascular Chinese Patent Medicine revenue, sales, average price and gross margin, recent developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cardiovascular Chinese Patent Medicine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Sales Channels. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Cardiovascular Chinese Patent Medicine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Oral
- Injection
- Hospital
- Pharmacy
- Clinic
- Beijing Tongrentang
- Tasly Pharmaceutical
- Shaanxi Buchang Pharmaceutical
- Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited
- Dr.Willmar Schwabe GmbH & Co. KG
- Shanxi Guang Yu Yuan Limited Company of Chinese Medicine
- KPC Pharmaceuticals
- Sinopharm Zhijun
- Shijiazhuang Yiling Pharmaceutical
- Shanxi Liye Pharmaceutical
- Shineway Pharmaceutical
- Guangzhou Baiyunshan Xingqun Pharmaceutical
- Jilin Xingxing Technology Pharmaceutical
- Sinopharm Zhonglian Pharmaceutical
- Beijing Peking University WBL Biotech
- Yunnan Weihe Pharmaceuticals
- Guangxi Wuzhou Pharmaceuticals (GROUP)
- SPH NO.1 Biochemical & Pharmaceutical
- Chengdu Baiyu Pharmaceutical
1. How big is the global Cardiovascular Chinese Patent Medicine market?
2. What is the demand of the global Cardiovascular Chinese Patent Medicine market?
3. What is the year over year growth of the global Cardiovascular Chinese Patent Medicine market?
4. What is the production and production value of the global Cardiovascular Chinese Patent Medicine market?
5. Who are the key producers in the global Cardiovascular Chinese Patent Medicine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cardiovascular Chinese Patent Medicine Introduction
1.2 World Cardiovascular Chinese Patent Medicine Supply & Forecast
1.2.1 World Cardiovascular Chinese Patent Medicine Production Value (2017 & 2021 & 2028)
1.2.2 World Cardiovascular Chinese Patent Medicine Production (2017-2028)
1.2.3 World Cardiovascular Chinese Patent Medicine Pricing Trends (2017-2028)
1.3 World Cardiovascular Chinese Patent Medicine Production by Region
1.3.1 World Cardiovascular Chinese Patent Medicine Production Value by Region (2017-2028)
1.3.2 World Cardiovascular Chinese Patent Medicine Production by Region (2017-2028)
1.3.3 World Cardiovascular Chinese Patent Medicine Average Price by Region (2017-2028)
1.3.4 North America Cardiovascular Chinese Patent Medicine Production (2017-2028)
1.3.5 Europe Cardiovascular Chinese Patent Medicine Production (2017-2028)
1.3.6 China Cardiovascular Chinese Patent Medicine Production (2017-2028)
1.3.7 Japan Cardiovascular Chinese Patent Medicine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cardiovascular Chinese Patent Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cardiovascular Chinese Patent Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cardiovascular Chinese Patent Medicine Demand (2017-2028)
2.2 World Cardiovascular Chinese Patent Medicine Consumption by Region
2.2.1 World Cardiovascular Chinese Patent Medicine Consumption by Region (2017-2022)
2.2.2 World Cardiovascular Chinese Patent Medicine Consumption Forecast by Region (2023-2028)
2.3 United States Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.4 China Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.5 Europe Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.6 Japan Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.7 South Korea Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.8 ASEAN Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.9 India Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
3 WORLD CARDIOVASCULAR CHINESE PATENT MEDICINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cardiovascular Chinese Patent Medicine Production Value by Manufacturer (2017-2022)
3.2 World Cardiovascular Chinese Patent Medicine Production by Manufacturer (2017-2022)
3.3 World Cardiovascular Chinese Patent Medicine Average Price by Manufacturer (2017-2022)
3.4 Cardiovascular Chinese Patent Medicine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cardiovascular Chinese Patent Medicine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cardiovascular Chinese Patent Medicine in 2021
3.5.3 Global Concentration Ratios (CR8) for Cardiovascular Chinese Patent Medicine in 2021
3.6 Cardiovascular Chinese Patent Medicine Market: Overall Company Footprint Analysis
3.6.1 Cardiovascular Chinese Patent Medicine Market: Region Footprint
3.6.2 Cardiovascular Chinese Patent Medicine Market: Company Product Type Footprint
3.6.3 Cardiovascular Chinese Patent Medicine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cardiovascular Chinese Patent Medicine Production Value Comparison
4.1.1 United States VS China: Cardiovascular Chinese Patent Medicine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Cardiovascular Chinese Patent Medicine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Cardiovascular Chinese Patent Medicine Production Comparison
4.2.1 United States VS China: Cardiovascular Chinese Patent Medicine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Cardiovascular Chinese Patent Medicine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Cardiovascular Chinese Patent Medicine Consumption Comparison
4.3.1 United States VS China: Cardiovascular Chinese Patent Medicine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Cardiovascular Chinese Patent Medicine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Cardiovascular Chinese Patent Medicine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Cardiovascular Chinese Patent Medicine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022)
4.5 China Cardiovascular Chinese Patent Medicine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Cardiovascular Chinese Patent Medicine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Cardiovascular Chinese Patent Medicine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Cardiovascular Chinese Patent Medicine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Cardiovascular Chinese Patent Medicine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Segment by Type
5.3.1 World Cardiovascular Chinese Patent Medicine Production by Type (2017-2028)
5.3.2 World Cardiovascular Chinese Patent Medicine Production Value by Type (2017-2028)
5.3.3 World Cardiovascular Chinese Patent Medicine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY SALES CHANNELS
6.1 World Cardiovascular Chinese Patent Medicine Market Size Overview by Sales Channels: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Sales Channels
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Clinic
6.3 Market Segment by Sales Channels
6.3.1 World Cardiovascular Chinese Patent Medicine Production by Sales Channels (2017-2028)
6.3.2 World Cardiovascular Chinese Patent Medicine Production Value by Sales Channels (2017-2028)
6.3.3 World Cardiovascular Chinese Patent Medicine Average Price by Sales Channels (2017-2028)
7 COMPANY PROFILES
7.1 Beijing Tongrentang
7.1.1 Beijing Tongrentang Details
7.1.2 Beijing Tongrentang Major Business
7.1.3 Beijing Tongrentang Cardiovascular Chinese Patent Medicine Product and Services
7.1.4 Beijing Tongrentang Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Beijing Tongrentang Recent Developments/Updates
7.1.6 Beijing Tongrentang Competitive Strengths & Weaknesses
7.2 Tasly Pharmaceutical
7.2.1 Tasly Pharmaceutical Details
7.2.2 Tasly Pharmaceutical Major Business
7.2.3 Tasly Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.2.4 Tasly Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Tasly Pharmaceutical Recent Developments/Updates
7.2.6 Tasly Pharmaceutical Competitive Strengths & Weaknesses
7.3 Shaanxi Buchang Pharmaceutical
7.3.1 Shaanxi Buchang Pharmaceutical Details
7.3.2 Shaanxi Buchang Pharmaceutical Major Business
7.3.3 Shaanxi Buchang Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.3.4 Shaanxi Buchang Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Shaanxi Buchang Pharmaceutical Recent Developments/Updates
7.3.6 Shaanxi Buchang Pharmaceutical Competitive Strengths & Weaknesses
7.4 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited
7.4.1 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Details
7.4.2 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Major Business
7.4.3 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular Chinese Patent Medicine Product and Services
7.4.4 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Recent Developments/Updates
7.4.6 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Competitive Strengths & Weaknesses
7.5 Dr.Willmar Schwabe GmbH & Co. KG
7.5.1 Dr.Willmar Schwabe GmbH & Co. KG Details
7.5.2 Dr.Willmar Schwabe GmbH & Co. KG Major Business
7.5.3 Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular Chinese Patent Medicine Product and Services
7.5.4 Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Dr.Willmar Schwabe GmbH & Co. KG Recent Developments/Updates
7.5.6 Dr.Willmar Schwabe GmbH & Co. KG Competitive Strengths & Weaknesses
7.6 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine
7.6.1 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Details
7.6.2 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Major Business
7.6.3 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular Chinese Patent Medicine Product and Services
7.6.4 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Recent Developments/Updates
7.6.6 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Competitive Strengths & Weaknesses
7.7 KPC Pharmaceuticals
7.7.1 KPC Pharmaceuticals Details
7.7.2 KPC Pharmaceuticals Major Business
7.7.3 KPC Pharmaceuticals Cardiovascular Chinese Patent Medicine Product and Services
7.7.4 KPC Pharmaceuticals Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 KPC Pharmaceuticals Recent Developments/Updates
7.7.6 KPC Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Sinopharm Zhijun
7.8.1 Sinopharm Zhijun Details
7.8.2 Sinopharm Zhijun Major Business
7.8.3 Sinopharm Zhijun Cardiovascular Chinese Patent Medicine Product and Services
7.8.4 Sinopharm Zhijun Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Sinopharm Zhijun Recent Developments/Updates
7.8.6 Sinopharm Zhijun Competitive Strengths & Weaknesses
7.9 Shijiazhuang Yiling Pharmaceutical
7.9.1 Shijiazhuang Yiling Pharmaceutical Details
7.9.2 Shijiazhuang Yiling Pharmaceutical Major Business
7.9.3 Shijiazhuang Yiling Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.9.4 Shijiazhuang Yiling Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Shijiazhuang Yiling Pharmaceutical Recent Developments/Updates
7.9.6 Shijiazhuang Yiling Pharmaceutical Competitive Strengths & Weaknesses
7.10 Shanxi Liye Pharmaceutical
7.10.1 Shanxi Liye Pharmaceutical Details
7.10.2 Shanxi Liye Pharmaceutical Major Business
7.10.3 Shanxi Liye Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.10.4 Shanxi Liye Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Shanxi Liye Pharmaceutical Recent Developments/Updates
7.10.6 Shanxi Liye Pharmaceutical Competitive Strengths & Weaknesses
7.11 Shineway Pharmaceutical
7.11.1 Shineway Pharmaceutical Details
7.11.2 Shineway Pharmaceutical Major Business
7.11.3 Shineway Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.11.4 Shineway Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Shineway Pharmaceutical Recent Developments/Updates
7.11.6 Shineway Pharmaceutical Competitive Strengths & Weaknesses
7.12 Guangzhou Baiyunshan Xingqun Pharmaceutical
7.12.1 Guangzhou Baiyunshan Xingqun Pharmaceutical Details
7.12.2 Guangzhou Baiyunshan Xingqun Pharmaceutical Major Business
7.12.3 Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.12.4 Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Guangzhou Baiyunshan Xingqun Pharmaceutical Recent Developments/Updates
7.12.6 Guangzhou Baiyunshan Xingqun Pharmaceutical Competitive Strengths & Weaknesses
7.13 Jilin Xingxing Technology Pharmaceutical
7.13.1 Jilin Xingxing Technology Pharmaceutical Details
7.13.2 Jilin Xingxing Technology Pharmaceutical Major Business
7.13.3 Jilin Xingxing Technology Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.13.4 Jilin Xingxing Technology Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Jilin Xingxing Technology Pharmaceutical Recent Developments/Updates
7.13.6 Jilin Xingxing Technology Pharmaceutical Competitive Strengths & Weaknesses
7.14 Sinopharm Zhonglian Pharmaceutical
7.14.1 Sinopharm Zhonglian Pharmaceutical Details
7.14.2 Sinopharm Zhonglian Pharmaceutical Major Business
7.14.3 Sinopharm Zhonglian Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.14.4 Sinopharm Zhonglian Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Sinopharm Zhonglian Pharmaceutical Recent Developments/Updates
7.14.6 Sinopharm Zhonglian Pharmaceutical Competitive Strengths & Weaknesses
7.15 Beijing Peking University WBL Biotech
7.15.1 Beijing Peking University WBL Biotech Details
7.15.2 Beijing Peking University WBL Biotech Major Business
7.15.3 Beijing Peking University WBL Biotech Cardiovascular Chinese Patent Medicine Product and Services
7.15.4 Beijing Peking University WBL Biotech Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Beijing Peking University WBL Biotech Recent Developments/Updates
7.15.6 Beijing Peking University WBL Biotech Competitive Strengths & Weaknesses
7.16 Yunnan Weihe Pharmaceuticals
7.16.1 Yunnan Weihe Pharmaceuticals Details
7.16.2 Yunnan Weihe Pharmaceuticals Major Business
7.16.3 Yunnan Weihe Pharmaceuticals Cardiovascular Chinese Patent Medicine Product and Services
7.16.4 Yunnan Weihe Pharmaceuticals Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Yunnan Weihe Pharmaceuticals Recent Developments/Updates
7.16.6 Yunnan Weihe Pharmaceuticals Competitive Strengths & Weaknesses
7.17 Guangxi Wuzhou Pharmaceuticals (GROUP)
7.17.1 Guangxi Wuzhou Pharmaceuticals (GROUP) Details
7.17.2 Guangxi Wuzhou Pharmaceuticals (GROUP) Major Business
7.17.3 Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular Chinese Patent Medicine Product and Services
7.17.4 Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Guangxi Wuzhou Pharmaceuticals (GROUP) Recent Developments/Updates
7.17.6 Guangxi Wuzhou Pharmaceuticals (GROUP) Competitive Strengths & Weaknesses
7.18 SPH NO.1 Biochemical & Pharmaceutical
7.18.1 SPH NO.1 Biochemical & Pharmaceutical Details
7.18.2 SPH NO.1 Biochemical & Pharmaceutical Major Business
7.18.3 SPH NO.1 Biochemical & Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.18.4 SPH NO.1 Biochemical & Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 SPH NO.1 Biochemical & Pharmaceutical Recent Developments/Updates
7.18.6 SPH NO.1 Biochemical & Pharmaceutical Competitive Strengths & Weaknesses
7.19 Chengdu Baiyu Pharmaceutical
7.19.1 Chengdu Baiyu Pharmaceutical Details
7.19.2 Chengdu Baiyu Pharmaceutical Major Business
7.19.3 Chengdu Baiyu Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.19.4 Chengdu Baiyu Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
7.19.6 Chengdu Baiyu Pharmaceutical Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Cardiovascular Chinese Patent Medicine and Key Manufacturers
8.2 Cardiovascular Chinese Patent Medicine Manufacturing Costs
8.3 Cardiovascular Chinese Patent Medicine Production Process
8.4 Cardiovascular Chinese Patent Medicine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Cardiovascular Chinese Patent Medicine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Cardiovascular Chinese Patent Medicine Typical Distributors
9.3 Cardiovascular Chinese Patent Medicine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
1.1 Cardiovascular Chinese Patent Medicine Introduction
1.2 World Cardiovascular Chinese Patent Medicine Supply & Forecast
1.2.1 World Cardiovascular Chinese Patent Medicine Production Value (2017 & 2021 & 2028)
1.2.2 World Cardiovascular Chinese Patent Medicine Production (2017-2028)
1.2.3 World Cardiovascular Chinese Patent Medicine Pricing Trends (2017-2028)
1.3 World Cardiovascular Chinese Patent Medicine Production by Region
1.3.1 World Cardiovascular Chinese Patent Medicine Production Value by Region (2017-2028)
1.3.2 World Cardiovascular Chinese Patent Medicine Production by Region (2017-2028)
1.3.3 World Cardiovascular Chinese Patent Medicine Average Price by Region (2017-2028)
1.3.4 North America Cardiovascular Chinese Patent Medicine Production (2017-2028)
1.3.5 Europe Cardiovascular Chinese Patent Medicine Production (2017-2028)
1.3.6 China Cardiovascular Chinese Patent Medicine Production (2017-2028)
1.3.7 Japan Cardiovascular Chinese Patent Medicine Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cardiovascular Chinese Patent Medicine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cardiovascular Chinese Patent Medicine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cardiovascular Chinese Patent Medicine Demand (2017-2028)
2.2 World Cardiovascular Chinese Patent Medicine Consumption by Region
2.2.1 World Cardiovascular Chinese Patent Medicine Consumption by Region (2017-2022)
2.2.2 World Cardiovascular Chinese Patent Medicine Consumption Forecast by Region (2023-2028)
2.3 United States Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.4 China Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.5 Europe Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.6 Japan Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.7 South Korea Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.8 ASEAN Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
2.9 India Cardiovascular Chinese Patent Medicine Consumption (2017-2028)
3 WORLD CARDIOVASCULAR CHINESE PATENT MEDICINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Cardiovascular Chinese Patent Medicine Production Value by Manufacturer (2017-2022)
3.2 World Cardiovascular Chinese Patent Medicine Production by Manufacturer (2017-2022)
3.3 World Cardiovascular Chinese Patent Medicine Average Price by Manufacturer (2017-2022)
3.4 Cardiovascular Chinese Patent Medicine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Cardiovascular Chinese Patent Medicine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Cardiovascular Chinese Patent Medicine in 2021
3.5.3 Global Concentration Ratios (CR8) for Cardiovascular Chinese Patent Medicine in 2021
3.6 Cardiovascular Chinese Patent Medicine Market: Overall Company Footprint Analysis
3.6.1 Cardiovascular Chinese Patent Medicine Market: Region Footprint
3.6.2 Cardiovascular Chinese Patent Medicine Market: Company Product Type Footprint
3.6.3 Cardiovascular Chinese Patent Medicine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Cardiovascular Chinese Patent Medicine Production Value Comparison
4.1.1 United States VS China: Cardiovascular Chinese Patent Medicine Production Value Comparison (2017 & 2021 & 2028)
4.1.2 United States VS China: Cardiovascular Chinese Patent Medicine Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Cardiovascular Chinese Patent Medicine Production Comparison
4.2.1 United States VS China: Cardiovascular Chinese Patent Medicine Production Comparison (2017 & 2021 & 2028)
4.2.2 United States VS China: Cardiovascular Chinese Patent Medicine Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Cardiovascular Chinese Patent Medicine Consumption Comparison
4.3.1 United States VS China: Cardiovascular Chinese Patent Medicine Consumption Comparison (2017 & 2021 & 2028)
4.3.2 United States VS China: Cardiovascular Chinese Patent Medicine Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Cardiovascular Chinese Patent Medicine Key Producers and Market Share, 2017-2022
4.4.1 Major Manufacturer of Cardiovascular Chinese Patent Medicine in United States, Company Headquarters and Production Place (States, Country)
4.4.2 United States Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022)
4.4.3 United States Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022)
4.5 China Cardiovascular Chinese Patent Medicine Key Producers and Market Share, 2017-2022
4.5.1 Major Manufacturer of Cardiovascular Chinese Patent Medicine in China, Company Headquarters and Production Place (Province, Country)
4.5.2 China Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022)
4.5.3 China Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Cardiovascular Chinese Patent Medicine Key Producers and Market Share, 2017-2022
4.6.1 Major Manufacturer of Cardiovascular Chinese Patent Medicine in Rest of World, Company Headquarters and Production Place (State, Country)
4.6.2 Rest of World Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022)
4.6.3 Rest of World Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022)
5 MARKET ANALYSIS BY TYPE
5.1 World Cardiovascular Chinese Patent Medicine Market Size Overview by Type: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Type
5.2.1 Oral
5.2.2 Injection
5.3 Market Segment by Type
5.3.1 World Cardiovascular Chinese Patent Medicine Production by Type (2017-2028)
5.3.2 World Cardiovascular Chinese Patent Medicine Production Value by Type (2017-2028)
5.3.3 World Cardiovascular Chinese Patent Medicine Average Price by Type (2017-2028)
6 MARKET ANALYSIS BY SALES CHANNELS
6.1 World Cardiovascular Chinese Patent Medicine Market Size Overview by Sales Channels: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Sales Channels
6.2.1 Hospital
6.2.2 Pharmacy
6.2.3 Clinic
6.3 Market Segment by Sales Channels
6.3.1 World Cardiovascular Chinese Patent Medicine Production by Sales Channels (2017-2028)
6.3.2 World Cardiovascular Chinese Patent Medicine Production Value by Sales Channels (2017-2028)
6.3.3 World Cardiovascular Chinese Patent Medicine Average Price by Sales Channels (2017-2028)
7 COMPANY PROFILES
7.1 Beijing Tongrentang
7.1.1 Beijing Tongrentang Details
7.1.2 Beijing Tongrentang Major Business
7.1.3 Beijing Tongrentang Cardiovascular Chinese Patent Medicine Product and Services
7.1.4 Beijing Tongrentang Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.1.5 Beijing Tongrentang Recent Developments/Updates
7.1.6 Beijing Tongrentang Competitive Strengths & Weaknesses
7.2 Tasly Pharmaceutical
7.2.1 Tasly Pharmaceutical Details
7.2.2 Tasly Pharmaceutical Major Business
7.2.3 Tasly Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.2.4 Tasly Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.2.5 Tasly Pharmaceutical Recent Developments/Updates
7.2.6 Tasly Pharmaceutical Competitive Strengths & Weaknesses
7.3 Shaanxi Buchang Pharmaceutical
7.3.1 Shaanxi Buchang Pharmaceutical Details
7.3.2 Shaanxi Buchang Pharmaceutical Major Business
7.3.3 Shaanxi Buchang Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.3.4 Shaanxi Buchang Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.3.5 Shaanxi Buchang Pharmaceutical Recent Developments/Updates
7.3.6 Shaanxi Buchang Pharmaceutical Competitive Strengths & Weaknesses
7.4 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited
7.4.1 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Details
7.4.2 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Major Business
7.4.3 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular Chinese Patent Medicine Product and Services
7.4.4 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.4.5 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Recent Developments/Updates
7.4.6 Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Competitive Strengths & Weaknesses
7.5 Dr.Willmar Schwabe GmbH & Co. KG
7.5.1 Dr.Willmar Schwabe GmbH & Co. KG Details
7.5.2 Dr.Willmar Schwabe GmbH & Co. KG Major Business
7.5.3 Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular Chinese Patent Medicine Product and Services
7.5.4 Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.5.5 Dr.Willmar Schwabe GmbH & Co. KG Recent Developments/Updates
7.5.6 Dr.Willmar Schwabe GmbH & Co. KG Competitive Strengths & Weaknesses
7.6 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine
7.6.1 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Details
7.6.2 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Major Business
7.6.3 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular Chinese Patent Medicine Product and Services
7.6.4 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.6.5 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Recent Developments/Updates
7.6.6 Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Competitive Strengths & Weaknesses
7.7 KPC Pharmaceuticals
7.7.1 KPC Pharmaceuticals Details
7.7.2 KPC Pharmaceuticals Major Business
7.7.3 KPC Pharmaceuticals Cardiovascular Chinese Patent Medicine Product and Services
7.7.4 KPC Pharmaceuticals Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.7.5 KPC Pharmaceuticals Recent Developments/Updates
7.7.6 KPC Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Sinopharm Zhijun
7.8.1 Sinopharm Zhijun Details
7.8.2 Sinopharm Zhijun Major Business
7.8.3 Sinopharm Zhijun Cardiovascular Chinese Patent Medicine Product and Services
7.8.4 Sinopharm Zhijun Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.8.5 Sinopharm Zhijun Recent Developments/Updates
7.8.6 Sinopharm Zhijun Competitive Strengths & Weaknesses
7.9 Shijiazhuang Yiling Pharmaceutical
7.9.1 Shijiazhuang Yiling Pharmaceutical Details
7.9.2 Shijiazhuang Yiling Pharmaceutical Major Business
7.9.3 Shijiazhuang Yiling Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.9.4 Shijiazhuang Yiling Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.9.5 Shijiazhuang Yiling Pharmaceutical Recent Developments/Updates
7.9.6 Shijiazhuang Yiling Pharmaceutical Competitive Strengths & Weaknesses
7.10 Shanxi Liye Pharmaceutical
7.10.1 Shanxi Liye Pharmaceutical Details
7.10.2 Shanxi Liye Pharmaceutical Major Business
7.10.3 Shanxi Liye Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.10.4 Shanxi Liye Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.10.5 Shanxi Liye Pharmaceutical Recent Developments/Updates
7.10.6 Shanxi Liye Pharmaceutical Competitive Strengths & Weaknesses
7.11 Shineway Pharmaceutical
7.11.1 Shineway Pharmaceutical Details
7.11.2 Shineway Pharmaceutical Major Business
7.11.3 Shineway Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.11.4 Shineway Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.11.5 Shineway Pharmaceutical Recent Developments/Updates
7.11.6 Shineway Pharmaceutical Competitive Strengths & Weaknesses
7.12 Guangzhou Baiyunshan Xingqun Pharmaceutical
7.12.1 Guangzhou Baiyunshan Xingqun Pharmaceutical Details
7.12.2 Guangzhou Baiyunshan Xingqun Pharmaceutical Major Business
7.12.3 Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.12.4 Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.12.5 Guangzhou Baiyunshan Xingqun Pharmaceutical Recent Developments/Updates
7.12.6 Guangzhou Baiyunshan Xingqun Pharmaceutical Competitive Strengths & Weaknesses
7.13 Jilin Xingxing Technology Pharmaceutical
7.13.1 Jilin Xingxing Technology Pharmaceutical Details
7.13.2 Jilin Xingxing Technology Pharmaceutical Major Business
7.13.3 Jilin Xingxing Technology Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.13.4 Jilin Xingxing Technology Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.13.5 Jilin Xingxing Technology Pharmaceutical Recent Developments/Updates
7.13.6 Jilin Xingxing Technology Pharmaceutical Competitive Strengths & Weaknesses
7.14 Sinopharm Zhonglian Pharmaceutical
7.14.1 Sinopharm Zhonglian Pharmaceutical Details
7.14.2 Sinopharm Zhonglian Pharmaceutical Major Business
7.14.3 Sinopharm Zhonglian Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.14.4 Sinopharm Zhonglian Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.14.5 Sinopharm Zhonglian Pharmaceutical Recent Developments/Updates
7.14.6 Sinopharm Zhonglian Pharmaceutical Competitive Strengths & Weaknesses
7.15 Beijing Peking University WBL Biotech
7.15.1 Beijing Peking University WBL Biotech Details
7.15.2 Beijing Peking University WBL Biotech Major Business
7.15.3 Beijing Peking University WBL Biotech Cardiovascular Chinese Patent Medicine Product and Services
7.15.4 Beijing Peking University WBL Biotech Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.15.5 Beijing Peking University WBL Biotech Recent Developments/Updates
7.15.6 Beijing Peking University WBL Biotech Competitive Strengths & Weaknesses
7.16 Yunnan Weihe Pharmaceuticals
7.16.1 Yunnan Weihe Pharmaceuticals Details
7.16.2 Yunnan Weihe Pharmaceuticals Major Business
7.16.3 Yunnan Weihe Pharmaceuticals Cardiovascular Chinese Patent Medicine Product and Services
7.16.4 Yunnan Weihe Pharmaceuticals Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.16.5 Yunnan Weihe Pharmaceuticals Recent Developments/Updates
7.16.6 Yunnan Weihe Pharmaceuticals Competitive Strengths & Weaknesses
7.17 Guangxi Wuzhou Pharmaceuticals (GROUP)
7.17.1 Guangxi Wuzhou Pharmaceuticals (GROUP) Details
7.17.2 Guangxi Wuzhou Pharmaceuticals (GROUP) Major Business
7.17.3 Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular Chinese Patent Medicine Product and Services
7.17.4 Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.17.5 Guangxi Wuzhou Pharmaceuticals (GROUP) Recent Developments/Updates
7.17.6 Guangxi Wuzhou Pharmaceuticals (GROUP) Competitive Strengths & Weaknesses
7.18 SPH NO.1 Biochemical & Pharmaceutical
7.18.1 SPH NO.1 Biochemical & Pharmaceutical Details
7.18.2 SPH NO.1 Biochemical & Pharmaceutical Major Business
7.18.3 SPH NO.1 Biochemical & Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.18.4 SPH NO.1 Biochemical & Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.18.5 SPH NO.1 Biochemical & Pharmaceutical Recent Developments/Updates
7.18.6 SPH NO.1 Biochemical & Pharmaceutical Competitive Strengths & Weaknesses
7.19 Chengdu Baiyu Pharmaceutical
7.19.1 Chengdu Baiyu Pharmaceutical Details
7.19.2 Chengdu Baiyu Pharmaceutical Major Business
7.19.3 Chengdu Baiyu Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
7.19.4 Chengdu Baiyu Pharmaceutical Cardiovascular Chinese Patent Medicine Production, Price, Value, Gross Margin and Market Share (2017-2022)
7.19.5 Chengdu Baiyu Pharmaceutical Recent Developments/Updates
7.19.6 Chengdu Baiyu Pharmaceutical Competitive Strengths & Weaknesses
8 RAW MATERIAL AND INDUSTRY CHAIN
8.1 Raw Material of Cardiovascular Chinese Patent Medicine and Key Manufacturers
8.2 Cardiovascular Chinese Patent Medicine Manufacturing Costs
8.3 Cardiovascular Chinese Patent Medicine Production Process
8.4 Cardiovascular Chinese Patent Medicine Industrial Chain
9 DISTRIBUTION CHANNEL ANALYSIS
9.1 Distribution Channel Breakdown for Cardiovascular Chinese Patent Medicine Shipments (%): 2017-2028
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Cardiovascular Chinese Patent Medicine Typical Distributors
9.3 Cardiovascular Chinese Patent Medicine Typical Customers
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer
LIST OF TABLES
Table 1. World Cardiovascular Chinese Patent Medicine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Cardiovascular Chinese Patent Medicine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Cardiovascular Chinese Patent Medicine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Region (2017-2022)
Table 5. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Region (2023-2028)
Table 6. World Cardiovascular Chinese Patent Medicine Production by Region (2017-2022) & (K Units)
Table 7. World Cardiovascular Chinese Patent Medicine Production by Region (2023-2028) & (K Units)
Table 8. World Cardiovascular Chinese Patent Medicine Production Market Share by Region (2017-2022)
Table 9. World Cardiovascular Chinese Patent Medicine Production Market Share by Region (2023-2028)
Table 10. World Cardiovascular Chinese Patent Medicine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Cardiovascular Chinese Patent Medicine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Cardiovascular Chinese Patent Medicine Major Market Trends
Table 13. World Cardiovascular Chinese Patent Medicine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Cardiovascular Chinese Patent Medicine Consumption by Region (2017-2022) & (K Units)
Table 15. World Cardiovascular Chinese Patent Medicine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Cardiovascular Chinese Patent Medicine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Cardiovascular Chinese Patent Medicine Producers in 2021
Table 18. World Cardiovascular Chinese Patent Medicine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Cardiovascular Chinese Patent Medicine Producers in 2021
Table 20. World Cardiovascular Chinese Patent Medicine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Cardiovascular Chinese Patent Medicine Company Evaluation Quadrant
Table 22. World Cardiovascular Chinese Patent Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Cardiovascular Chinese Patent Medicine Production Site of Key Manufacturer
Table 24. Cardiovascular Chinese Patent Medicine Market: Company Product Type Footprint
Table 25. Cardiovascular Chinese Patent Medicine Market: Company Product Application Footprint
Table 26. Cardiovascular Chinese Patent Medicine Competitive Factors
Table 27. Cardiovascular Chinese Patent Medicine New Entrant and Capacity Expansion Plans
Table 28. Cardiovascular Chinese Patent Medicine Mergers & Acquisitions Activity
Table 29. United States VS China Cardiovascular Chinese Patent Medicine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Cardiovascular Chinese Patent Medicine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Cardiovascular Chinese Patent Medicine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Cardiovascular Chinese Patent Medicine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Cardiovascular Chinese Patent Medicine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Cardiovascular Chinese Patent Medicine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Cardiovascular Chinese Patent Medicine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Cardiovascular Chinese Patent Medicine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Cardiovascular Chinese Patent Medicine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Cardiovascular Chinese Patent Medicine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Cardiovascular Chinese Patent Medicine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Cardiovascular Chinese Patent Medicine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Cardiovascular Chinese Patent Medicine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Cardiovascular Chinese Patent Medicine Production by Type (2017-2022) & (K Units)
Table 49. World Cardiovascular Chinese Patent Medicine Production by Type (2023-2028) & (K Units)
Table 50. World Cardiovascular Chinese Patent Medicine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Cardiovascular Chinese Patent Medicine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Cardiovascular Chinese Patent Medicine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Cardiovascular Chinese Patent Medicine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Cardiovascular Chinese Patent Medicine Production Value by Sales Channels, (USD Million), 2017 & 2021 & 2028
Table 55. World Cardiovascular Chinese Patent Medicine Production by Sales Channels (2017-2022) & (K Units)
Table 56. World Cardiovascular Chinese Patent Medicine Production by Sales Channels (2023-2028) & (K Units)
Table 57. World Cardiovascular Chinese Patent Medicine Production Value by Sales Channels (2017-2022) & (USD Million)
Table 58. World Cardiovascular Chinese Patent Medicine Production Value by Sales Channels (2023-2028) & (USD Million)
Table 59. World Cardiovascular Chinese Patent Medicine Average Price by Sales Channels (2017-2022) & (US$/Unit)
Table 60. World Cardiovascular Chinese Patent Medicine Average Price by Sales Channels (2023-2028) & (US$/Unit)
Table 61. Beijing Tongrentang Basic Information, Manufacturing Base and Competitors
Table 62. Beijing Tongrentang Major Business
Table 63. Beijing Tongrentang Cardiovascular Chinese Patent Medicine Product and Services
Table 64. Beijing Tongrentang Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Beijing Tongrentang Recent Developments/Updates
Table 66. Beijing Tongrentang Competitive Strengths & Weaknesses
Table 67. Tasly Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Tasly Pharmaceutical Major Business
Table 69. Tasly Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 70. Tasly Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Tasly Pharmaceutical Recent Developments/Updates
Table 72. Tasly Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Shaanxi Buchang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Shaanxi Buchang Pharmaceutical Major Business
Table 75. Shaanxi Buchang Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 76. Shaanxi Buchang Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Shaanxi Buchang Pharmaceutical Recent Developments/Updates
Table 78. Shaanxi Buchang Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Basic Information, Manufacturing Base and Competitors
Table 80. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Major Business
Table 81. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular Chinese Patent Medicine Product and Services
Table 82. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Recent Developments/Updates
Table 84. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Competitive Strengths & Weaknesses
Table 85. Dr.Willmar Schwabe GmbH & Co. KG Basic Information, Manufacturing Base and Competitors
Table 86. Dr.Willmar Schwabe GmbH & Co. KG Major Business
Table 87. Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular Chinese Patent Medicine Product and Services
Table 88. Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Dr.Willmar Schwabe GmbH & Co. KG Recent Developments/Updates
Table 90. Dr.Willmar Schwabe GmbH & Co. KG Competitive Strengths & Weaknesses
Table 91. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Basic Information, Manufacturing Base and Competitors
Table 92. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Major Business
Table 93. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular Chinese Patent Medicine Product and Services
Table 94. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Recent Developments/Updates
Table 96. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Competitive Strengths & Weaknesses
Table 97. KPC Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. KPC Pharmaceuticals Major Business
Table 99. KPC Pharmaceuticals Cardiovascular Chinese Patent Medicine Product and Services
Table 100. KPC Pharmaceuticals Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. KPC Pharmaceuticals Recent Developments/Updates
Table 102. KPC Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Sinopharm Zhijun Basic Information, Manufacturing Base and Competitors
Table 104. Sinopharm Zhijun Major Business
Table 105. Sinopharm Zhijun Cardiovascular Chinese Patent Medicine Product and Services
Table 106. Sinopharm Zhijun Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Sinopharm Zhijun Recent Developments/Updates
Table 108. Sinopharm Zhijun Competitive Strengths & Weaknesses
Table 109. Shijiazhuang Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Shijiazhuang Yiling Pharmaceutical Major Business
Table 111. Shijiazhuang Yiling Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 112. Shijiazhuang Yiling Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Shijiazhuang Yiling Pharmaceutical Recent Developments/Updates
Table 114. Shijiazhuang Yiling Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Shanxi Liye Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Shanxi Liye Pharmaceutical Major Business
Table 117. Shanxi Liye Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 118. Shanxi Liye Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Shanxi Liye Pharmaceutical Recent Developments/Updates
Table 120. Shanxi Liye Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Shineway Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Shineway Pharmaceutical Major Business
Table 123. Shineway Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 124. Shineway Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Shineway Pharmaceutical Recent Developments/Updates
Table 126. Shineway Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Guangzhou Baiyunshan Xingqun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. Guangzhou Baiyunshan Xingqun Pharmaceutical Major Business
Table 129. Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 130. Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Guangzhou Baiyunshan Xingqun Pharmaceutical Recent Developments/Updates
Table 132. Guangzhou Baiyunshan Xingqun Pharmaceutical Competitive Strengths & Weaknesses
Table 133. Jilin Xingxing Technology Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Jilin Xingxing Technology Pharmaceutical Major Business
Table 135. Jilin Xingxing Technology Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 136. Jilin Xingxing Technology Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Jilin Xingxing Technology Pharmaceutical Recent Developments/Updates
Table 138. Jilin Xingxing Technology Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Sinopharm Zhonglian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Sinopharm Zhonglian Pharmaceutical Major Business
Table 141. Sinopharm Zhonglian Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 142. Sinopharm Zhonglian Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Sinopharm Zhonglian Pharmaceutical Recent Developments/Updates
Table 144. Sinopharm Zhonglian Pharmaceutical Competitive Strengths & Weaknesses
Table 145. Beijing Peking University WBL Biotech Basic Information, Manufacturing Base and Competitors
Table 146. Beijing Peking University WBL Biotech Major Business
Table 147. Beijing Peking University WBL Biotech Cardiovascular Chinese Patent Medicine Product and Services
Table 148. Beijing Peking University WBL Biotech Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Beijing Peking University WBL Biotech Recent Developments/Updates
Table 150. Beijing Peking University WBL Biotech Competitive Strengths & Weaknesses
Table 151. Yunnan Weihe Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 152. Yunnan Weihe Pharmaceuticals Major Business
Table 153. Yunnan Weihe Pharmaceuticals Cardiovascular Chinese Patent Medicine Product and Services
Table 154. Yunnan Weihe Pharmaceuticals Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Yunnan Weihe Pharmaceuticals Recent Developments/Updates
Table 156. Yunnan Weihe Pharmaceuticals Competitive Strengths & Weaknesses
Table 157. Guangxi Wuzhou Pharmaceuticals (GROUP) Basic Information, Manufacturing Base and Competitors
Table 158. Guangxi Wuzhou Pharmaceuticals (GROUP) Major Business
Table 159. Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular Chinese Patent Medicine Product and Services
Table 160. Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Guangxi Wuzhou Pharmaceuticals (GROUP) Recent Developments/Updates
Table 162. Guangxi Wuzhou Pharmaceuticals (GROUP) Competitive Strengths & Weaknesses
Table 163. SPH NO.1 Biochemical & Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 164. SPH NO.1 Biochemical & Pharmaceutical Major Business
Table 165. SPH NO.1 Biochemical & Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 166. SPH NO.1 Biochemical & Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. SPH NO.1 Biochemical & Pharmaceutical Recent Developments/Updates
Table 168. Chengdu Baiyu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 169. Chengdu Baiyu Pharmaceutical Major Business
Table 170. Chengdu Baiyu Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 171. Chengdu Baiyu Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 172. Cardiovascular Chinese Patent Medicine Raw Material
Table 173. Key Manufacturers of Cardiovascular Chinese Patent Medicine Raw Materials
Table 174. Cardiovascular Chinese Patent Medicine Typical Distributors
Table 175. Cardiovascular Chinese Patent Medicine Typical Customers
Table 1. World Cardiovascular Chinese Patent Medicine Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Cardiovascular Chinese Patent Medicine Production Value by Region (2017-2022) & (USD Million)
Table 3. World Cardiovascular Chinese Patent Medicine Production Value by Region (2023-2028) & (USD Million)
Table 4. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Region (2017-2022)
Table 5. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Region (2023-2028)
Table 6. World Cardiovascular Chinese Patent Medicine Production by Region (2017-2022) & (K Units)
Table 7. World Cardiovascular Chinese Patent Medicine Production by Region (2023-2028) & (K Units)
Table 8. World Cardiovascular Chinese Patent Medicine Production Market Share by Region (2017-2022)
Table 9. World Cardiovascular Chinese Patent Medicine Production Market Share by Region (2023-2028)
Table 10. World Cardiovascular Chinese Patent Medicine Average Price by Region (2017-2022) & (US$/Unit)
Table 11. World Cardiovascular Chinese Patent Medicine Average Price by Region (2023-2028) & (US$/Unit)
Table 12. Cardiovascular Chinese Patent Medicine Major Market Trends
Table 13. World Cardiovascular Chinese Patent Medicine Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (K Units)
Table 14. World Cardiovascular Chinese Patent Medicine Consumption by Region (2017-2022) & (K Units)
Table 15. World Cardiovascular Chinese Patent Medicine Consumption Forecast by Region (2023-2028) & (K Units)
Table 16. World Cardiovascular Chinese Patent Medicine Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Cardiovascular Chinese Patent Medicine Producers in 2021
Table 18. World Cardiovascular Chinese Patent Medicine Production by Manufacturer (2017-2022) & (K Units)
Table 19. Production Market Share of Key Cardiovascular Chinese Patent Medicine Producers in 2021
Table 20. World Cardiovascular Chinese Patent Medicine Average Price by Manufacturer (2017-2022) & (US$/Unit)
Table 21. Global Cardiovascular Chinese Patent Medicine Company Evaluation Quadrant
Table 22. World Cardiovascular Chinese Patent Medicine Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Cardiovascular Chinese Patent Medicine Production Site of Key Manufacturer
Table 24. Cardiovascular Chinese Patent Medicine Market: Company Product Type Footprint
Table 25. Cardiovascular Chinese Patent Medicine Market: Company Product Application Footprint
Table 26. Cardiovascular Chinese Patent Medicine Competitive Factors
Table 27. Cardiovascular Chinese Patent Medicine New Entrant and Capacity Expansion Plans
Table 28. Cardiovascular Chinese Patent Medicine Mergers & Acquisitions Activity
Table 29. United States VS China Cardiovascular Chinese Patent Medicine Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Cardiovascular Chinese Patent Medicine Production Comparison, (2017 & 2021 & 2028) & (K Units)
Table 31. United States VS China Cardiovascular Chinese Patent Medicine Consumption Comparison, (2017 & 2021 & 2028) & (K Units)
Table 32. Major Manufacturer of Cardiovascular Chinese Patent Medicine in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Cardiovascular Chinese Patent Medicine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 36. United States Cardiovascular Chinese Patent Medicine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Cardiovascular Chinese Patent Medicine in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Cardiovascular Chinese Patent Medicine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 41. China Cardiovascular Chinese Patent Medicine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Cardiovascular Chinese Patent Medicine in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Cardiovascular Chinese Patent Medicine Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Cardiovascular Chinese Patent Medicine Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Cardiovascular Chinese Patent Medicine Production by Domestic Manufacturer, (2017-2022) & (K Units)
Table 46. Rest of World Cardiovascular Chinese Patent Medicine Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Cardiovascular Chinese Patent Medicine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Table 48. World Cardiovascular Chinese Patent Medicine Production by Type (2017-2022) & (K Units)
Table 49. World Cardiovascular Chinese Patent Medicine Production by Type (2023-2028) & (K Units)
Table 50. World Cardiovascular Chinese Patent Medicine Production Value by Type (2017-2022) & (USD Million)
Table 51. World Cardiovascular Chinese Patent Medicine Production Value by Type (2023-2028) & (USD Million)
Table 52. World Cardiovascular Chinese Patent Medicine Average Price by Type (2017-2022) & (US$/Unit)
Table 53. World Cardiovascular Chinese Patent Medicine Average Price by Type (2023-2028) & (US$/Unit)
Table 54. World Cardiovascular Chinese Patent Medicine Production Value by Sales Channels, (USD Million), 2017 & 2021 & 2028
Table 55. World Cardiovascular Chinese Patent Medicine Production by Sales Channels (2017-2022) & (K Units)
Table 56. World Cardiovascular Chinese Patent Medicine Production by Sales Channels (2023-2028) & (K Units)
Table 57. World Cardiovascular Chinese Patent Medicine Production Value by Sales Channels (2017-2022) & (USD Million)
Table 58. World Cardiovascular Chinese Patent Medicine Production Value by Sales Channels (2023-2028) & (USD Million)
Table 59. World Cardiovascular Chinese Patent Medicine Average Price by Sales Channels (2017-2022) & (US$/Unit)
Table 60. World Cardiovascular Chinese Patent Medicine Average Price by Sales Channels (2023-2028) & (US$/Unit)
Table 61. Beijing Tongrentang Basic Information, Manufacturing Base and Competitors
Table 62. Beijing Tongrentang Major Business
Table 63. Beijing Tongrentang Cardiovascular Chinese Patent Medicine Product and Services
Table 64. Beijing Tongrentang Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Beijing Tongrentang Recent Developments/Updates
Table 66. Beijing Tongrentang Competitive Strengths & Weaknesses
Table 67. Tasly Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Tasly Pharmaceutical Major Business
Table 69. Tasly Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 70. Tasly Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. Tasly Pharmaceutical Recent Developments/Updates
Table 72. Tasly Pharmaceutical Competitive Strengths & Weaknesses
Table 73. Shaanxi Buchang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Shaanxi Buchang Pharmaceutical Major Business
Table 75. Shaanxi Buchang Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 76. Shaanxi Buchang Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Shaanxi Buchang Pharmaceutical Recent Developments/Updates
Table 78. Shaanxi Buchang Pharmaceutical Competitive Strengths & Weaknesses
Table 79. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Basic Information, Manufacturing Base and Competitors
Table 80. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Major Business
Table 81. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular Chinese Patent Medicine Product and Services
Table 82. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Recent Developments/Updates
Table 84. Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Company Limited Competitive Strengths & Weaknesses
Table 85. Dr.Willmar Schwabe GmbH & Co. KG Basic Information, Manufacturing Base and Competitors
Table 86. Dr.Willmar Schwabe GmbH & Co. KG Major Business
Table 87. Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular Chinese Patent Medicine Product and Services
Table 88. Dr.Willmar Schwabe GmbH & Co. KG Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. Dr.Willmar Schwabe GmbH & Co. KG Recent Developments/Updates
Table 90. Dr.Willmar Schwabe GmbH & Co. KG Competitive Strengths & Weaknesses
Table 91. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Basic Information, Manufacturing Base and Competitors
Table 92. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Major Business
Table 93. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular Chinese Patent Medicine Product and Services
Table 94. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Recent Developments/Updates
Table 96. Shanxi Guang Yu Yuan Limited Company of Chinese Medicine Competitive Strengths & Weaknesses
Table 97. KPC Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 98. KPC Pharmaceuticals Major Business
Table 99. KPC Pharmaceuticals Cardiovascular Chinese Patent Medicine Product and Services
Table 100. KPC Pharmaceuticals Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. KPC Pharmaceuticals Recent Developments/Updates
Table 102. KPC Pharmaceuticals Competitive Strengths & Weaknesses
Table 103. Sinopharm Zhijun Basic Information, Manufacturing Base and Competitors
Table 104. Sinopharm Zhijun Major Business
Table 105. Sinopharm Zhijun Cardiovascular Chinese Patent Medicine Product and Services
Table 106. Sinopharm Zhijun Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Sinopharm Zhijun Recent Developments/Updates
Table 108. Sinopharm Zhijun Competitive Strengths & Weaknesses
Table 109. Shijiazhuang Yiling Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 110. Shijiazhuang Yiling Pharmaceutical Major Business
Table 111. Shijiazhuang Yiling Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 112. Shijiazhuang Yiling Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Shijiazhuang Yiling Pharmaceutical Recent Developments/Updates
Table 114. Shijiazhuang Yiling Pharmaceutical Competitive Strengths & Weaknesses
Table 115. Shanxi Liye Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 116. Shanxi Liye Pharmaceutical Major Business
Table 117. Shanxi Liye Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 118. Shanxi Liye Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Shanxi Liye Pharmaceutical Recent Developments/Updates
Table 120. Shanxi Liye Pharmaceutical Competitive Strengths & Weaknesses
Table 121. Shineway Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 122. Shineway Pharmaceutical Major Business
Table 123. Shineway Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 124. Shineway Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Shineway Pharmaceutical Recent Developments/Updates
Table 126. Shineway Pharmaceutical Competitive Strengths & Weaknesses
Table 127. Guangzhou Baiyunshan Xingqun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 128. Guangzhou Baiyunshan Xingqun Pharmaceutical Major Business
Table 129. Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 130. Guangzhou Baiyunshan Xingqun Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Guangzhou Baiyunshan Xingqun Pharmaceutical Recent Developments/Updates
Table 132. Guangzhou Baiyunshan Xingqun Pharmaceutical Competitive Strengths & Weaknesses
Table 133. Jilin Xingxing Technology Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 134. Jilin Xingxing Technology Pharmaceutical Major Business
Table 135. Jilin Xingxing Technology Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 136. Jilin Xingxing Technology Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Jilin Xingxing Technology Pharmaceutical Recent Developments/Updates
Table 138. Jilin Xingxing Technology Pharmaceutical Competitive Strengths & Weaknesses
Table 139. Sinopharm Zhonglian Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 140. Sinopharm Zhonglian Pharmaceutical Major Business
Table 141. Sinopharm Zhonglian Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 142. Sinopharm Zhonglian Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Sinopharm Zhonglian Pharmaceutical Recent Developments/Updates
Table 144. Sinopharm Zhonglian Pharmaceutical Competitive Strengths & Weaknesses
Table 145. Beijing Peking University WBL Biotech Basic Information, Manufacturing Base and Competitors
Table 146. Beijing Peking University WBL Biotech Major Business
Table 147. Beijing Peking University WBL Biotech Cardiovascular Chinese Patent Medicine Product and Services
Table 148. Beijing Peking University WBL Biotech Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 149. Beijing Peking University WBL Biotech Recent Developments/Updates
Table 150. Beijing Peking University WBL Biotech Competitive Strengths & Weaknesses
Table 151. Yunnan Weihe Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 152. Yunnan Weihe Pharmaceuticals Major Business
Table 153. Yunnan Weihe Pharmaceuticals Cardiovascular Chinese Patent Medicine Product and Services
Table 154. Yunnan Weihe Pharmaceuticals Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 155. Yunnan Weihe Pharmaceuticals Recent Developments/Updates
Table 156. Yunnan Weihe Pharmaceuticals Competitive Strengths & Weaknesses
Table 157. Guangxi Wuzhou Pharmaceuticals (GROUP) Basic Information, Manufacturing Base and Competitors
Table 158. Guangxi Wuzhou Pharmaceuticals (GROUP) Major Business
Table 159. Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular Chinese Patent Medicine Product and Services
Table 160. Guangxi Wuzhou Pharmaceuticals (GROUP) Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 161. Guangxi Wuzhou Pharmaceuticals (GROUP) Recent Developments/Updates
Table 162. Guangxi Wuzhou Pharmaceuticals (GROUP) Competitive Strengths & Weaknesses
Table 163. SPH NO.1 Biochemical & Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 164. SPH NO.1 Biochemical & Pharmaceutical Major Business
Table 165. SPH NO.1 Biochemical & Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 166. SPH NO.1 Biochemical & Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 167. SPH NO.1 Biochemical & Pharmaceutical Recent Developments/Updates
Table 168. Chengdu Baiyu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 169. Chengdu Baiyu Pharmaceutical Major Business
Table 170. Chengdu Baiyu Pharmaceutical Cardiovascular Chinese Patent Medicine Product and Services
Table 171. Chengdu Baiyu Pharmaceutical Cardiovascular Chinese Patent Medicine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 172. Cardiovascular Chinese Patent Medicine Raw Material
Table 173. Key Manufacturers of Cardiovascular Chinese Patent Medicine Raw Materials
Table 174. Cardiovascular Chinese Patent Medicine Typical Distributors
Table 175. Cardiovascular Chinese Patent Medicine Typical Customers
LIST OF FIGURES
Figure 1. Cardiovascular Chinese Patent Medicine Picture
Figure 2. World Cardiovascular Chinese Patent Medicine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Cardiovascular Chinese Patent Medicine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Cardiovascular Chinese Patent Medicine Production (2017-2028) & (K Units)
Figure 5. World Cardiovascular Chinese Patent Medicine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Region (2017-2028)
Figure 7. World Cardiovascular Chinese Patent Medicine Production Market Share by Region (2017-2028)
Figure 8. North America Cardiovascular Chinese Patent Medicine Production (2017-2028) & (K Units)
Figure 9. Europe Cardiovascular Chinese Patent Medicine Production (2017-2028) & (K Units)
Figure 10. China Cardiovascular Chinese Patent Medicine Production (2017-2028) & (K Units)
Figure 11. Japan Cardiovascular Chinese Patent Medicine Production (2017-2028) & (K Units)
Figure 12. Cardiovascular Chinese Patent Medicine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cardiovascular Chinese Patent Medicine Demand (2017-2028) & (K Units)
Figure 15. World Cardiovascular Chinese Patent Medicine Consumption Market Share by Region (2017-2028)
Figure 16. United States Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 17. China Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 18. Europe Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 19. Japan Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 22. India Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Cardiovascular Chinese Patent Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cardiovascular Chinese Patent Medicine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cardiovascular Chinese Patent Medicine Markets in 2021
Figure 26. United States VS China: Cardiovascular Chinese Patent Medicine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Cardiovascular Chinese Patent Medicine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Cardiovascular Chinese Patent Medicine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Cardiovascular Chinese Patent Medicine in United States
Figure 30. Key Producers and Market Share of Cardiovascular Chinese Patent Medicine in China
Figure 31. Key Producers and Market Share of Cardiovascular Chinese Patent Medicine in Rest of World
Figure 32. World Cardiovascular Chinese Patent Medicine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Type in 2021
Figure 34. Oral
Figure 35. Injection
Figure 36. World Cardiovascular Chinese Patent Medicine Production Market Share by Type (2017-2028)
Figure 37. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Type (2017-2028)
Figure 38. World Cardiovascular Chinese Patent Medicine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Cardiovascular Chinese Patent Medicine Production Value by Sales Channels, (USD Million), 2017 & 2021 & 2028
Figure 40. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Sales Channels in 2021
Figure 41. Hospital
Figure 42. Pharmacy
Figure 43. Clinic
Figure 44. World Cardiovascular Chinese Patent Medicine Production Market Share by Sales Channels (2017-2028)
Figure 45. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Sales Channels (2017-2028)
Figure 46. World Cardiovascular Chinese Patent Medicine Average Price by Sales Channels (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Cardiovascular Chinese Patent Medicine in 2021
Figure 48. Manufacturing Process Analysis of Cardiovascular Chinese Patent Medicine
Figure 49. Cardiovascular Chinese Patent Medicine Industrial Chain
Figure 50. Distribution Channel Breakdown for Cardiovascular Chinese Patent Medicine Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Cardiovascular Chinese Patent Medicine Picture
Figure 2. World Cardiovascular Chinese Patent Medicine Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Cardiovascular Chinese Patent Medicine Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Cardiovascular Chinese Patent Medicine Production (2017-2028) & (K Units)
Figure 5. World Cardiovascular Chinese Patent Medicine Average Price (2017-2028) & (US$/Unit)
Figure 6. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Region (2017-2028)
Figure 7. World Cardiovascular Chinese Patent Medicine Production Market Share by Region (2017-2028)
Figure 8. North America Cardiovascular Chinese Patent Medicine Production (2017-2028) & (K Units)
Figure 9. Europe Cardiovascular Chinese Patent Medicine Production (2017-2028) & (K Units)
Figure 10. China Cardiovascular Chinese Patent Medicine Production (2017-2028) & (K Units)
Figure 11. Japan Cardiovascular Chinese Patent Medicine Production (2017-2028) & (K Units)
Figure 12. Cardiovascular Chinese Patent Medicine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Cardiovascular Chinese Patent Medicine Demand (2017-2028) & (K Units)
Figure 15. World Cardiovascular Chinese Patent Medicine Consumption Market Share by Region (2017-2028)
Figure 16. United States Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 17. China Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 18. Europe Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 19. Japan Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 20. South Korea Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 21. ASEAN Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 22. India Cardiovascular Chinese Patent Medicine Consumption (2017-2028) & (K Units)
Figure 23. Producer Shipments of Cardiovascular Chinese Patent Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Cardiovascular Chinese Patent Medicine Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Cardiovascular Chinese Patent Medicine Markets in 2021
Figure 26. United States VS China: Cardiovascular Chinese Patent Medicine Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Cardiovascular Chinese Patent Medicine Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Cardiovascular Chinese Patent Medicine Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Cardiovascular Chinese Patent Medicine in United States
Figure 30. Key Producers and Market Share of Cardiovascular Chinese Patent Medicine in China
Figure 31. Key Producers and Market Share of Cardiovascular Chinese Patent Medicine in Rest of World
Figure 32. World Cardiovascular Chinese Patent Medicine Production Value by Type, (USD Million), 2017 & 2021 & 2028
Figure 33. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Type in 2021
Figure 34. Oral
Figure 35. Injection
Figure 36. World Cardiovascular Chinese Patent Medicine Production Market Share by Type (2017-2028)
Figure 37. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Type (2017-2028)
Figure 38. World Cardiovascular Chinese Patent Medicine Average Price by Type (2017-2028) & (US$/Unit)
Figure 39. World Cardiovascular Chinese Patent Medicine Production Value by Sales Channels, (USD Million), 2017 & 2021 & 2028
Figure 40. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Sales Channels in 2021
Figure 41. Hospital
Figure 42. Pharmacy
Figure 43. Clinic
Figure 44. World Cardiovascular Chinese Patent Medicine Production Market Share by Sales Channels (2017-2028)
Figure 45. World Cardiovascular Chinese Patent Medicine Production Value Market Share by Sales Channels (2017-2028)
Figure 46. World Cardiovascular Chinese Patent Medicine Average Price by Sales Channels (2017-2028) & (US$/Unit)
Figure 47. Manufacturing Cost Structure Analysis of Cardiovascular Chinese Patent Medicine in 2021
Figure 48. Manufacturing Process Analysis of Cardiovascular Chinese Patent Medicine
Figure 49. Cardiovascular Chinese Patent Medicine Industrial Chain
Figure 50. Distribution Channel Breakdown for Cardiovascular Chinese Patent Medicine Shipments (%): 2017-2028
Figure 51. Direct Channel Pros & Cons
Figure 52. Indirect Channel Pros & Cons
Figure 53. Methodology
Figure 54. Research Process and Data Source
